This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| National Strategic Plan on HIV, TB and STIs | |
|---|---|
| Title | National Strategic Plan on HIV, TB and STIs |
| Jurisdiction | Ministry of Health; World Health Organization |
| Date adopted | 2020s |
| Period | 5 years |
| Status | Active |
National Strategic Plan on HIV, TB and STIs The National Strategic Plan on HIV, TB and STIs is a multi-year policy instrument that coordinates national responses to HIV/AIDS, tuberculosis, and sexually transmitted infection control aligned with international frameworks such as the Sustainable Development Goals, the Global Fund, and the UNAIDS Fast-Track targets. It synthesizes evidence from World Health Organization, Centers for Disease Control and Prevention, UNAIDS, Stop TB Partnership, and regional public health authorities to set priorities, targets, and operational guidance across clinical, public health, and social sectors.
The plan responds to epidemiological trends documented by World Health Organization, UNAIDS, and national surveillance systems demonstrating intersections between HIV/AIDS, tuberculosis, and sexually transmitted infection burdens in key populations identified by studies from Johns Hopkins University, Imperial College London, and University of Cape Town. Historical precedents include strategic frameworks influenced by the Millennium Development Goals era, the Global Fund investment architecture, and lessons learned from programmatic responses to Ebola and COVID-19 pandemic. Policy rationales reference normative guidance from World Health Organization, UNAIDS, UNICEF, UNFPA, and legal obligations under instruments like the International Health Regulations (2005). The rationale emphasizes addressing social determinants documented by researchers at Harvard University, London School of Hygiene & Tropical Medicine, and Columbia University and leveraging partnerships with Gavi, the Vaccine Alliance, The Global Fund, and bilateral agencies such as United States Agency for International Development.
Goals align with targets set by Sustainable Development Goals and UNAIDS 95-95-95 targets, aiming to reduce incidence, morbidity, and mortality associated with HIV/AIDS, tuberculosis, and sexually transmitted infections while addressing co-morbidities cited in publications from Mayo Clinic, Royal College of Physicians, and Karolinska Institutet. Specific objectives draw on epidemiological modeling from Imperial College London, cost-effectiveness analyses by World Bank, and programmatic evaluations by Centers for Disease Control and Prevention to expand testing, treatment, prevention, and harm-reduction interventions for populations identified in research at University of Pretoria, Makerere University, and University of Lagos.
Priority interventions mirror evidence-based packages promoted by World Health Organization and UNAIDS and include scale-up of antiretroviral therapy endorsed by PEPFAR, expansion of latent tuberculosis infection management consistent with Stop TB Partnership guidance, and STI syndromic management informed by ECDC recommendations. Interventions encompass biomedical measures such as pre-exposure prophylaxis championed by Centers for Disease Control and Prevention and British HIV Association, vaccination strategies inspired by Gavi, the Vaccine Alliance and Bill & Melinda Gates Foundation-funded research, and structural actions influenced by legal reforms referenced in reports from Human Rights Watch and Amnesty International. Program elements integrate service delivery models piloted at Médecins Sans Frontières sites, community-based approaches developed by AIDS Healthcare Foundation, and differentiated care innovations from Partners In Health and academic consortia at University of Washington.
Governance arrangements draw on multi-sectoral coordination mechanisms used by United Nations Development Programme, Global Fund, and national coordinating bodies such as National AIDS Council. The framework specifies roles for ministries like Ministry of Health and institutions including National Institutes of Health, provincial health departments, and research partners such as Wellcome Trust–funded centers. Implementation pathways reference procurement and supply chain models from UNICEF and Global Drug Facility, human resources strategies influenced by the World Health Organization's Health Workforce Department, and legal-institutional reforms aligned with decisions from Constitutional Court of South Africa and policy analyses by Brookings Institution.
Monitoring and evaluation systems use standardized indicators consistent with UNAIDS and World Health Organization guidance, integrating surveillance platforms compatible with DHIS2 and analytics approaches used in studies at Bill & Melinda Gates Foundation–supported projects. Core indicators include incidence, prevalence, treatment coverage, viral suppression, case detection, and drug-resistance trends documented by World Health Organization and European Centre for Disease Prevention and Control, with modeling inputs from Imperial College London and operational research from London School of Hygiene & Tropical Medicine. Evaluation structures describe independent reviews by academic partners such as University of Oxford and oversight by bodies modeled on the Global Fund's technical review panels.
Financing strategies combine domestic resource mobilization guided by fiscal analyses from the World Bank and International Monetary Fund with external financing through mechanisms including Global Fund, PEPFAR, Gavi, the Vaccine Alliance, and philanthropic support from Bill & Melinda Gates Foundation and Clinton Health Access Initiative. Budgeting approaches reference costed plans used in UNAIDS investment cases and procurement financing models developed by UNICEF and World Health Organization, while sustainability scenarios draw on economic modeling from OECD and programmatic studies by Kaiser Family Foundation.
Stakeholder engagement mandates participation by civil society organizations such as AIDS Healthcare Foundation, Treatment Action Campaign, International Planned Parenthood Federation, and affected-population networks modeled on Global Network of People Living with HIV and International Community of Women Living with HIV. Community involvement leverages community health worker programs informed by Partners In Health, harm-reduction advocacy from INPUD, and peer-led models documented by UNAIDS and Médecins Sans Frontières, with accountability mechanisms inspired by social accountability initiatives from Transparency International and civil society monitoring approaches employed by Human Rights Watch.